Christopher G. Chorley
AstraZeneca (United Kingdom)(GB)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Click Chemistry and Applications, Synthesis and biological activity, Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Discovery of a Potent and Selective EGFR Inhibitor (AZD9291) of Both Sensitizing and T790M Resistance Mutations That Spares the Wild Type Form of the Receptor(2014)591 cited
- → Structure- and Reactivity-Based Development of Covalent Inhibitors of the Activating and Gatekeeper Mutant Forms of the Epidermal Growth Factor Receptor (EGFR)(2013)258 cited